Abstract
Diabetic dyslipidaemia refers to the triad of elevated levels of triglycerides and small, dense LDL-C particles and low levels of HDL-C. These lipid abnormalities are largely responsible for the increased risk of cardiovascular complications in patients with diabetes. This case study outlines a rational approach to the treatment of each of these lipid abnormalities and emphasises the importance of both lowering the LDL-C and raising the HDL-C in high-risk individuals. Combination drug therapy will often be necessary to achieve treatment goals in these patients.
Original language | English (US) |
---|---|
Pages (from-to) | 25-30 |
Number of pages | 6 |
Journal | British Journal of Diabetes and Vascular Disease |
Volume | 7 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2007 |
Keywords
- Atherogenic dyslipidaemia
- Diabetes
- Diabetic dyslipidaemia
- Fibrates
- Niacin
- Statins
ASJC Scopus subject areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
- Cardiology and Cardiovascular Medicine